$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 18/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 18/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 52.03 | 52,500 | 2,731,575 | 0 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 52.03 | 33,079 | 1,721,100 | 52,500 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 569.42 | 700 | 398,594 | 28,251 | 29 K to 28.3 K (-2.42 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 568.57 | 3,040 | 1,728,453 | 28,951 | 32 K to 29 K (-9.50 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 567.35 | 3,753 | 2,129,265 | 31,991 | 35.7 K to 32 K (-10.50 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 566.47 | 7,297 | 4,133,532 | 35,744 | 43 K to 35.7 K (-16.95 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 565.49 | 5,984 | 3,383,892 | 43,041 | 49 K to 43 K (-12.21 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 564.54 | 3,000 | 1,693,620 | 49,025 | 52 K to 49 K (-5.77 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 563.58 | 2,195 | 1,237,058 | 52,025 | 54.2 K to 52 K (-4.05 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 562.45 | 2,077 | 1,168,209 | 54,220 | 56.3 K to 54.2 K (-3.69 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 561.55 | 4,988 | 2,801,011 | 56,297 | 61.3 K to 56.3 K (-8.14 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 560.53 | 3,231 | 1,811,072 | 61,285 | 64.5 K to 61.3 K (-5.01 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 559.20 | 500 | 279,600 | 64,516 | 65 K to 64.5 K (-0.77 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 558.43 | 2,118 | 1,182,755 | 65,016 | 67.1 K to 65 K (-3.15 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 557.59 | 600 | 334,554 | 67,134 | 67.7 K to 67.1 K (-0.89 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 556.92 | 100 | 55,692 | 67,734 | 67.8 K to 67.7 K (-0.15 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 555.77 | 28,217 | 15,682,162 | 67,834 | 96.1 K to 67.8 K (-29.38 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 52.03 | 52,500 | 2,731,575 | 96,051 | 43.6 K to 96.1 K (+120.55 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 555.77 | 17,779 | 9,881,035 | 43,551 | 61.3 K to 43.6 K (-28.99 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 52.03 | 33,079 | 1,721,100 | 61,330 | 28.3 K to 61.3 K (+117.09 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | M | 177.82 | 15,000 | 2,667,300 | 0 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 566.01 | 100 | 56,601 | 1,830 | 1.9 K to 1.8 K (-5.18 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 565.35 | 900 | 508,815 | 1,930 | 2.8 K to 1.9 K (-31.80 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 564.45 | 6,600 | 3,725,370 | 2,830 | 9.4 K to 2.8 K (-69.99 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 563.45 | 6,375 | 3,591,994 | 9,430 | 15.8 K to 9.4 K (-40.34 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 562.65 | 1,025 | 576,716 | 15,805 | 16.8 K to 15.8 K (-6.09 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Buy | M | 177.82 | 15,000 | 2,667,300 | 16,830 | 1.8 K to 16.8 K (+819.67 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Option Exercise | M | 391.92 | 5,118 | 2,005,847 | 10,235 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 569.20 | 13 | 7,400 | 643 | 656 to 643 (-1.98 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 568.37 | 609 | 346,137 | 656 | 1.3 K to 656 (-48.14 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 567.58 | 646 | 366,657 | 1,265 | 1.9 K to 1.3 K (-33.80 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 566.37 | 2,128 | 1,205,235 | 1,911 | 4 K to 1.9 K (-52.69 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 565.64 | 1,722 | 974,032 | 4,039 | 5.8 K to 4 K (-29.89 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Buy | M | 391.92 | 5,118 | 2,005,847 | 5,761 | 643 to 5.8 K (+795.96 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 520.01 | 9,212 | 4,790,332 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 413.33 | 10,838 | 4,479,671 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 380.95 | 4,960 | 1,889,512 | 2,479 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 376.69 | 7,830 | 2,949,483 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 371.40 | 3,784 | 1,405,378 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 273.67 | 8,500 | 2,326,195 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 177.82 | 5,000 | 889,100 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 556.31 | 4,731 | 2,631,903 | 28,843 | 33.6 K to 28.8 K (-14.09 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 555.25 | 1,595 | 885,624 | 33,574 | 35.2 K to 33.6 K (-4.54 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 554.33 | 2,172 | 1,204,005 | 35,169 | 37.3 K to 35.2 K (-5.82 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 553.16 | 5,423 | 2,999,787 | 37,341 | 42.8 K to 37.3 K (-12.68 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 552.33 | 6,477 | 3,577,441 | 42,764 | 49.2 K to 42.8 K (-13.15 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 551.66 | 7,341 | 4,049,736 | 49,241 | 56.6 K to 49.2 K (-12.97 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 550.58 | 7,295 | 4,016,481 | 56,582 | 63.9 K to 56.6 K (-11.42 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 549.35 | 4,113 | 2,259,477 | 63,877 | 68 K to 63.9 K (-6.05 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 548.17 | 2,597 | 1,423,597 | 67,990 | 70.6 K to 68 K (-3.68 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 547.37 | 1,597 | 874,150 | 70,587 | 72.2 K to 70.6 K (-2.21 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 546.31 | 1,631 | 891,032 | 72,184 | 73.8 K to 72.2 K (-2.21 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 545.34 | 1,390 | 758,023 | 73,815 | 75.2 K to 73.8 K (-1.85 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 544.57 | 405 | 220,551 | 75,205 | 75.6 K to 75.2 K (-0.54 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 543.12 | 1,260 | 684,331 | 75,610 | 76.9 K to 75.6 K (-1.64 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 542.66 | 496 | 269,159 | 76,870 | 77.4 K to 76.9 K (-0.64 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 541.66 | 1,600 | 866,656 | 77,366 | 79 K to 77.4 K (-2.03 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 556.62 | 1 | 557 | 78,966 | 79 K to 79 K (0.00 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 177.82 | 5,000 | 889,100 | 78,967 | 74 K to 79 K (+6.76 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 273.67 | 8,500 | 2,326,195 | 73,967 | 65.5 K to 74 K (+12.98 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 413.33 | 10,838 | 4,479,671 | 65,467 | 54.6 K to 65.5 K (+19.84 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 520.01 | 9,212 | 4,790,332 | 54,629 | 45.4 K to 54.6 K (+20.28 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 376.69 | 7,830 | 2,949,483 | 45,417 | 37.6 K to 45.4 K (+20.83 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 380.95 | 4,960 | 1,889,512 | 37,587 | 32.6 K to 37.6 K (+15.20 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 371.40 | 3,784 | 1,405,378 | 32,627 | 28.8 K to 32.6 K (+13.12 %) |
May 06 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 560.00 | 2,000 | 1,120,000 | 7,643 | 9.6 K to 7.6 K (-20.74 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 528.78 | 1 | 529 | 28,843 | 28.8 K to 28.8 K (0.00 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 527.44 | 1 | 527 | 28,844 | 28.8 K to 28.8 K (0.00 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 524.39 | 6 | 3,146 | 28,845 | 28.9 K to 28.8 K (-0.02 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 523.36 | 1 | 523 | 28,851 | 28.9 K to 28.9 K (0.00 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 522.61 | 7 | 3,658 | 28,852 | 28.9 K to 28.9 K (-0.02 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 521.36 | 17 | 8,863 | 28,859 | 28.9 K to 28.9 K (-0.06 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 520.46 | 22 | 11,450 | 28,876 | 28.9 K to 28.9 K (-0.08 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 519.54 | 18 | 9,352 | 28,898 | 28.9 K to 28.9 K (-0.06 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 518.57 | 15 | 7,779 | 28,916 | 28.9 K to 28.9 K (-0.05 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 517.41 | 12 | 6,209 | 28,931 | 28.9 K to 28.9 K (-0.04 %) |